ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Study Find Farmers Using Herbicides At High Risk for Some Lymphomas

September 12, 1986

Conferess Ok $10.9 Bil. NIH Bidget, OAM to Get $3.5 Million

October 15, 1993

SWOG Phase III Trial To Test Treatment For Inoperable, Locally Advanced NSCLC

September 28, 2001

In Congress: Conferees Approve 42 billion Increase For NIH Appropriations

October 29, 1999

CMX001 Reduces Adenovirus Progression and Viremia

August 30, 2013

Combination of Pill, Pap Test, May Result In False Positive

February 27, 2004